Types of Biotechnology: The Color Classification System

Red Biotechnology: Medicine and Pharmaceuticals

Red biotechnology develops drugs, vaccines, diagnostics, gene therapies, and medical devices using biological systems. It is the largest and most profitable branch, generating over $400 billion in annual revenue globally. The name comes from blood and the human body.

Biopharmaceuticals are drugs produced by living cells rather than chemical synthesis. Monoclonal antibodies (like adalimumab for autoimmune disease or trastuzumab for breast cancer) are manufactured in Chinese Hamster Ovary (CHO) cells growing in bioreactors. These drugs cannot be made through traditional chemistry because their complex protein structures require living cellular machinery to fold correctly.

Vaccines represent red biotech's most visible public health impact. Traditional vaccines use weakened or killed pathogens. Biotech vaccines use recombinant protein subunits (hepatitis B vaccine, produced in yeast since 1986), viral vectors (Johnson and Johnson COVID vaccine), or mRNA technology (Pfizer-BioNTech, Moderna). The mRNA platform can produce new vaccine candidates within days of identifying a pathogen's genetic sequence.

Gene Therapy treats disease by modifying a patient's own DNA. Luxturna restores vision in patients with inherited retinal dystrophy by delivering a functional RPE65 gene directly to retinal cells. Zolgensma treats spinal muscular atrophy in infants by delivering the SMN1 gene via an adeno-associated virus vector. Over 20 gene therapies have received regulatory approval as of 2026.

Diagnostics powered by biotechnology include PCR-based pathogen detection (which became household knowledge during COVID-19), DNA microarrays that screen for thousands of genetic variants simultaneously, and liquid biopsies that detect cancer DNA fragments circulating in blood. These tests enable earlier detection and more precise treatment decisions.

Green Biotechnology: Agriculture and Food

Green biotechnology improves crops, livestock, and food production using genetic tools. The green color references plant life and agricultural fields. This branch directly impacts food security for 8 billion people.

Genetically Modified Crops carry genes from other species that confer useful traits. Bt crops (corn, cotton, soybeans) contain a gene from Bacillus thuringiensis that produces an insecticidal protein, eliminating the need for chemical spraying against specific pests. Herbicide-tolerant crops allow farmers to spray broad-spectrum herbicides (glyphosate) that kill weeds but leave the crop unharmed, reducing the need for tillage and preventing soil erosion.

Gene-Edited Crops use CRISPR to modify existing plant genes without inserting foreign DNA. This approach produces non-browning mushrooms (by disabling the polyphenol oxidase gene), high-oleic soybeans (healthier oil profile through modified fatty acid desaturase genes), and disease-resistant wheat (by knocking out genes that fungi exploit for entry). Many countries regulate gene-edited crops less strictly than transgenic ones because no foreign DNA is introduced.

Biopesticides and Biofertilizers use living organisms or their products instead of synthetic chemicals. Bacillus thuringiensis sprays have been organic-farming staples for decades. Mycorrhizal fungi inoculants help plant roots absorb phosphorus more efficiently. Nitrogen-fixing bacteria (Rhizobium for legumes, engineered strains for cereals) reduce the need for synthetic nitrogen fertilizer, which is energy-intensive to produce and pollutes waterways.

Marker-Assisted Selection speeds traditional breeding by using DNA markers linked to desired traits. Rather than growing a plant to maturity and measuring its drought tolerance, breeders can screen seedlings for specific genetic markers and select the best candidates within days. This technique cuts breeding cycles from 10-15 years to 3-5 years and is widely used for traits controlled by multiple genes.

White Biotechnology: Industrial Processes

White biotechnology replaces chemical manufacturing processes with biological ones, typically using enzymes or microbial fermentation. The white color symbolizes cleaner, more sustainable production. This branch focuses on reducing energy consumption, toxic waste, and fossil fuel dependence in manufacturing.

Industrial Enzymes catalyze specific chemical reactions under mild conditions (low temperature, neutral pH, atmospheric pressure), replacing processes that traditionally required high heat, strong acids, or toxic solvents. The global industrial enzyme market exceeds $7 billion annually. Major applications include laundry detergents (proteases, lipases, amylases), food processing (pectinases for juice clarification, lactase for lactose-free dairy), textile manufacturing (cellulases for denim finishing), and paper production (xylanases for bleaching).

Biofuels convert biological feedstocks into liquid fuels. First-generation biofuels (corn ethanol, sugarcane ethanol) ferment plant sugars directly. Second-generation biofuels use cellulosic biomass (wood chips, corn stover, switchgrass) that does not compete with food production. Third-generation biofuels come from algae that grow in seawater on non-arable land. Global bioethanol production exceeds 30 billion gallons annually, displacing roughly 5% of global gasoline consumption.

Bioplastics are produced from renewable biological sources rather than petroleum. PLA (polylactic acid) from corn starch is used in packaging and 3D printing. PHA (polyhydroxyalkanoates) are produced directly by bacteria during fermentation and are fully biodegradable in soil and marine environments. While bioplastics currently represent less than 2% of total plastic production, manufacturing capacity is growing at 20-30% annually.

Bio-based Chemicals replace petroleum-derived chemicals with fermentation products. Succinic acid, 1,3-propanediol, lactic acid, and citric acid are all produced at scale through microbial fermentation. Companies like Genomatica engineer bacteria to produce butanediol (a polymer precursor) from sugar rather than natural gas, achieving cost parity while eliminating fossil fuel inputs.

Blue Biotechnology: Marine and Aquatic

Blue biotechnology exploits organisms from oceans, lakes, and rivers for useful applications. Marine environments contain unique organisms adapted to extreme conditions (high pressure, low light, high salinity) that produce novel chemicals not found on land.

Marine Pharmaceuticals derive from ocean organisms. Cytarabine (an anticancer drug) was developed from compounds discovered in Caribbean sea sponges. Ziconotide (a pain medication) comes from cone snail venom. Over 15,000 novel compounds have been isolated from marine organisms, with dozens in clinical trials for cancer, pain, inflammation, and infectious disease.

Aquaculture Genetics applies selective breeding and genetic engineering to farmed fish and shellfish. Atlantic salmon have been selectively bred to grow 2-3 times faster than wild populations. AquAdvantage salmon, genetically engineered with a growth hormone gene from Chinook salmon, reaches market size in 18 months instead of 36, reducing feed consumption and environmental footprint per kilogram of protein produced.

Algae-Based Products range from biofuels to nutritional supplements to bioplastics. Spirulina and Chlorella provide complete protein and essential fatty acids. Astaxanthin from Haematococcus algae is a powerful antioxidant used in aquaculture feed and human supplements. Algal DHA (docosahexaenoic acid) provides omega-3 fatty acids without depleting wild fish stocks.

Grey Biotechnology: Environmental Applications

Grey biotechnology applies biological processes to environmental protection, remediation, and sustainability. The grey color represents the industrial pollution and degraded environments this branch aims to clean.

Bioremediation uses microorganisms to break down environmental contaminants. Naturally occurring bacteria can degrade petroleum hydrocarbons, with biostimulation (adding nutrients to boost native bacteria) and bioaugmentation (introducing specialized strains) accelerating the process. The Exxon Valdez (1989) and Deepwater Horizon (2010) oil spills both benefited from bioremediation approaches.

Phytoremediation uses plants to extract or stabilize toxic contaminants in soil. Sunflowers accumulate heavy metals (lead, cadmium, zinc) in their tissues. Willow trees absorb organic solvents from contaminated groundwater. Indian mustard plants hyperaccumulate selenium. After harvesting, the contaminated plant biomass is incinerated at high temperature, concentrating the metals for safe disposal or recycling.

Wastewater Treatment relies heavily on microbial communities. Activated sludge systems use complex bacterial ecosystems to break down organic matter, nitrogen, and phosphorus. Constructed wetlands use plant-microbe partnerships to filter agricultural runoff. Anaerobic digesters convert sewage sludge into biogas (methane) that generates electricity while reducing waste volume by 60-70%.

Gold Biotechnology: Bioinformatics and Computational Biology

Gold biotechnology merges biology with computer science, statistics, and mathematics to analyze biological data and model living systems. The gold color represents the value extracted from biological data through computation. This branch has grown fastest since 2020 due to advances in artificial intelligence.

Genomic Analysis uses algorithms to assemble, annotate, and compare DNA sequences. A single human genome generates roughly 200 gigabytes of raw sequencing data that must be processed, aligned, and interpreted by specialized software. Population genomics compares thousands of genomes simultaneously to identify disease-associated variants, evolutionary relationships, and functional elements.

Protein Structure Prediction was transformed by AlphaFold (DeepMind, 2020), which predicted 3D structures for virtually all 200 million known proteins with accuracy rivaling experimental methods. Before AlphaFold, determining a single protein structure took months to years of laboratory work using X-ray crystallography or cryo-electron microscopy. Now, predicted structures are available instantly, accelerating drug design and enzyme engineering.

Drug Discovery AI uses machine learning to identify potential drug candidates, predict their safety profiles, and optimize their chemical properties before any laboratory synthesis. Companies like Recursion Pharmaceuticals, Insilico Medicine, and Isomorphic Labs (a DeepMind spinoff) have advanced AI-discovered drug candidates into clinical trials, compressing the typical 4-5 year discovery phase into 12-18 months.